Orthopedic Biomaterials Market

Orthopedic Biomaterials Market by Material (Ceramics & Bioactive Glasses, Metal, Calcium Phosphate Cement, Polymers, and Others), Application (Bio-resorbable Tissue Fixation, Orthopedic Implants, Joint Replacement/Reconstruction, Orthobiologics, Viscosupplementation, and Others), End-user (Specialty Clinics, Hospitals, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023– 2031

  • Report ID: HC-4950
  • Author: Growth Market Reports
  • Rating: 4.7
  • Total Reviews: 2
  • No. Of Pages: 197
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global orthopedic biomaterials market size was USD 15.5 Bn in 2022 and is likely to reach USD 38.7 Bn by 2031, expanding at a CAGR of 10.4% during 2023–2031. The market growth is attributed to an increase in the geriatric population, increasing musculoskeletal disorders, accidental injuries, and growing incidences of sports injuries.

Orthopedic biomaterials are artificial supporting materials used for joint replacement, reinforcement for fractures, spinal supportive products, and arthroscopy implant materials. Orthopedics is a branch of medicine dealing with musculoskeletal ailments and disorders of the muscles, bones, and joints. Supports for tissue repair, tissue substitutes, and bone repair have constituents as orthopedic biomaterials.

Global Orthopedic Biomaterials Market Outlook

Orthopedic biomaterials exhibit properties such as hardness to fractures, strength, ductility, stretchability, biocompatibility, and corrosion resistance.  These properties are preferred for increasing the load-bearing surface capacities of biomaterials in fixation procedures. Affected joints and bones are provided with adequate support through bioimplants. Enhanced biocompatibility with the human body is leading to the extensive use of orthopedic biomaterials.

COVID-19 Impact on Orthopedic Biomaterials Market

The market report finds that the COVID-19 pandemic adversely affected the global orthopedic biomaterials market, due to decreased footfalls of patients around the world for orthopedic treatments. The demand for orthopedic materials reduced considerably during the pandemic period. Non-essential expenses by consumers reduced significantly during the pandemic with changes in economic conditions and budgets of individuals affecting the growth of the orthopedic biomaterials industry.

Orthopedic Biomaterials Market Dynamics

The research report presents a complete market overview by providing detailed information about the current market trends, existing drivers, growth opportunities and potentials, and emerging challenges. The global orthopedic biomaterials market report has up-to-date insights about market scenarios that can shape the overall market performance and output during the forecast period, 2023 to 2031.

Global Orthopedic Biomaterials Market Dynamics

What are the Drivers of Orthopedic Biomaterials Market?

Increasing Geriatric Population

The geriatric population opting for biomaterials in orthopedic implanting procedures is on the rise which has boosted the growth of the global orthopedic biomaterials market. Modernized medical research methodology has made it possible to provide one-time solutions for orthopedic ailments. medical facilities are preferred by older adults for curing orthopedic ailments over repeated visits to hospitals and clinics.

The use of orthopedic biomaterials in procedures such as bio-implants reduces lengthy medical treatments which are desired by the geriatric population. Chronic problems faced by the elderly are related to joint movements. Biomaterial implants lend support for knee, joint, and hip troubles. Orthopedic biomaterial implants provide instant relief through knee replacement and joint & hip fixation. 

Growing Use in Sports Medicine

Rising sports activities around the world are boosting the number of young athletes. A flip side of the increased sporting activities has been a proportional upsurge in the number of sports injuries, driving the market growth of orthopedic device usage.

Sports injuries such as stress fractures and pulled muscles are commonly treated through sports medicine. Biomaterials are used as implants for treating musculoskeletal ailments of muscles, tendons, bones, cartilage, joints, and ligaments.

What are the Restraints of Orthopedic Biomaterials Market?

Rejection and Allergic Reactions of the Body

Implanted orthopedic materials can be rejected by the body causing strong allergic reactions. This factor can be one of the major restraints to the market growth in the coming years. Surface contamination of implants is responsible for spreading infections in the area of the implant. Reaction indications ranging from rashes to swellings have restrained the wide use of biomaterials.

Cases of implanted material intolerance by the human body have been found, causing severe pain in joints, tissue edema, and recurring effusion. Soreness and stiffness in joints have been reported as well. This is a major reason that may hamper the progress of the orthopedic biomaterials industry.

Which are the Opportunities in Orthopedic Biomaterials Market?

Advancements in Implant Technology

Major companies in healthcare manufacturing invest heavily in research & development to introduce better treatment resources for their consumers increasing the opportunities for market growth. Persistent R&D programs generate opportunities for introducing advanced biomaterial products.

Focus on the development of technologically advanced products gives the manufacturers in the orthopedic biomaterials industry an edge over their competitors with increased revenue growth. Such competent treatment offerings provide valuable prospects for the growth of the biomaterials industry. Growing demand for next-generation orthopedic biomaterials for varied orthopedic procedures provides a significant market expansion opportunity globally.

Rising Awareness Campaigns by Government and Private Institutions

Governments around the world and private organizations related to economic and social affairs have increased awareness about the use of orthopedic biomaterials. Clinical trials have created inquisitive interest amongst the masses creating opportunities for investments in the market.

The growing awareness is helpful in expanding the market opportunity to add new consumers. Information delivery of inexpensive orthopedic treatments using biomaterials that provide quick relief to patients provides excellent growth opportunities for the overall orthopedic biomaterials market.

Scope of Orthopedic Biomaterials Market Report

The global orthopedic biomaterials market research report includes an assessment of the market trends, market segments, and regional analysis of markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Orthopedic Biomaterials Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2020–2021

Forecast Period

2023–2031

Segmentation

Material (Ceramics & Bioactive Glasses, Metal, Calcium Phosphate Cement, Polymers, and Others), Application (Bio-resorbable Tissue Fixation, Orthopedic Implants, Joint Replacement/Reconstruction, Orthobiologics, Viscosupplementation, and Others), and End-user (Specialty Clinics, Hospitals, and Others)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast

Key Players Covered in the Report

Invibio Ltd; DSM; Globus Medical; Zimmer Biomet; Evonik Industries AG; Stryker; Exactech, Inc.; Smith+Nephew; Bioventus; Mitsubishi Chemical America, Inc.; CAM Bioceramics B.V.; Heraeus Holding; Medtronic; DJO, LLC; Arthrex, Inc. and NuVasive®, Inc.

Orthopedic Biomaterials Market Segment Insights

What Key Factors Contribute to the Rapid Expansion of the Ceramics & Bioactive Glasses Segment?

Increasing Adoption in Hard Tissue Repair Procedures

Based on material segment, the global orthopedic biomaterials market is classified into ceramics & bioactive glasses, metal, calcium phosphate cements, polymers, and others. The ceramics & bioactive glasses segment is expected to expected to dominate the market during the projection period owing to the rapid adoption of ceramics in various procedures for repairing hard tissues. Bioavailability and better efficiency of ceramics & bioactive glass material in orthopedics are expected to boost the segment growth.

Interbody synthesis procedures, joint reconstruction surgeries, and spine reconstruction surgeries make use of ceramics & bioactive glasses implants. Increased use of pedicle screws and synthetic cages for fixation procedures is driving the growth of the segment. Synthetic cages and pedicle screws are used in interbody cages in spinal surgeries that warrant disc removal for interbody fusion procedures. Bioinert ceramics, alumina in specific, are largely preferred in hip arthroplasty and joint arthroplasty.

The polymer segment is anticipated to expand at a rapid pace in the coming years due to their favorable biodegradable properties. According to clinical criteria, implant materials should neither produce bi-products harmful to the human body nor should they be rejected.

Biodegradable polymers from the family of hydroxy esters are used in surgical procedures. They include polyglycolic acid (PGA), polylactic acid (PLA), and copolymers (PLGA). Polymer usage in joint-related orthopedic procedures such as arthroplasties and bone void filling is increasing. The usage in the form of bone cement and load-bearing surfaces is expected to boost segment growth.

What are the Main Aspects Boosting the Orthopedic Implants Segment?

Growing Application in Fixation Procedures

On the basis of application, the market is segmented into bio-resorbable tissue fixation, orthopedic implants, joint replacement/reconstruction, orthobiologics, viscosupplementation, and others. The orthopedic implants segment is expected to expand significantly during the projected period with increasing applications in bone fracture fixations and disc degenerative conditions.

Biomaterials with superior load-bearing surfaces and capacities coupled with high corrosion resistance are in high demand. The high ductility, strength, and wear resistance of biomaterials make them a preferred choice as orthopedic bioimplants.

The orthobiologics segment is predicted projected to grow rapidly in the coming years owing to the increasing number of orthopedic surgeries for bone and joint reconstruction around the world. Orthobiologics are materials derived biologically for regeneration. The rising number of obese patients and increasing incidences of traumatic events are key factors driving the segment.

Orthobiologics procedures help the human body heal faster through the injection of substances by using body cells. Healing of ligament and tendon injuries can be expedited through orthobiologics to protect from osteoarthritis.

Global Orthopedic Biomaterials Market Application

What are the Main Aspects for Boosting the Hospitals Segment?

Increasing Orthopedic Ailments of the Rising Geriatric Population

Based on the end-user segment, the market is segmented into specialty clinics, hospitals, and others. The hospitals segment is expected to register a robust growth rate during the forecast period due to bone and joint-related orthopedic procedures. Elderly people require orthopedic biomaterials to be implanted in knee replacements, joints, ligaments, and tendons. Such corrective implanting procedures are possible in hospitals that have boosted segment growth.

The specialty clinics segment is projected to expand rapidly in the coming years owing to the advantages of catering to specific orthopedic ailments of the muscles, joints, and bones. Biomaterials for skeletal, muscle, and tissue diagnostics and engineering are widely used. The use of bone fixation materials made out of biomaterials is growing rapidly which is expected to boost the segment in the forecast period.

Why is North America Dominating the Orthopedic Biomaterials Market?

Increasing Advanced Healthcare Infrastructure

In terms of region, the global orthopedic biomaterials industry is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projected period due to the well-established healthcare infrastructure in North America.

The rising geriatric population of the region for bone disorder treatments and knee replacements. 
The market of Asia Pacific is anticipated to expand at a rapid pace during the forecast period. The segment growth is attributed to a rise in bone disorders and bone degenerative diseases in middle-income groups of Asia Pacific.

Growing government initiatives for biomaterial usage awareness and rapid expansion of medical facilities are further boosting the market in the Asia Pacific. China has one of the largest markets for joint health care and the market is projected to grow at a significant pace in the in the upcoming years.

Global Orthopedic Biomaterials Market Regions

Segments

The global orthopedic biomaterials market has been segmented on the basis of

Material

  • Ceramics & Bioactive Glasses
  • Metal
  • Calcium Phosphate Cement
  • Polymers
  • Others

Application

  • Bio-resorbable Tissue Fixation
  • Orthopedic Implants
  • Joint Replacement/Reconstruction
  • Orthobiologics
  • Viscosupplementation
  • Others

End-user

  • Specialty Clinics
  • Hospitals
  • Others

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Invibio Ltd
  • DSM
  • Globus Medical
  • Zimmer Biomet
  • Evonik Industries AG
  • Stryker
  • Exactech, Inc.
  • Smith+Nephew
  • Bioventus
  • Mitsubishi Chemical America, Inc.
  • CAM Bioceramics B.V.
  • Heraeus Holding
  • Medtronic
  • DJO, LLC
  • Arthrex, Inc.
  • NuVasive®, Inc.

Competitive Landscape

The competitive landscape of the global orthopedic biomaterials market report provides in-depth insights into the growth strategies and development initiatives implemented by the key players in the market.

Key players competing in the orthopedic biomaterials industry are Invibio Ltd; DSM; Globus Medical; Zimmer Biomet; Evonik Industries AG; Stryker; Exactech, Inc.; Smith+Nephew; Bioventus; Mitsubishi Chemical America, Inc.; CAM Bioceramics B.V.; Heraeus Holding; Medtronic; DJO, LLC; Arthrex, Inc. and NuVasive®, Inc.

  • On February 10, 2022, DePuy Synthes, an orthopedic unit of US healthcare giant Johnson & Johnson, acquired US-based foot and ankle company CrossRoads Extremity Systems.
  • On December 01, 2020, Zimmer Biomet a global solution provider for musculoskeletal disorders based in the US, acquired A&E Medical and its complete portfolio of sternal closure devices that include sternal sutures, cable systems, and rigid fixation along with punch products and pacing wires.
Global Orthopedic Biomaterials Market Share
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Orthopedic Biomaterials Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Orthopedic Biomaterials Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Orthopedic Biomaterials Market - Supply Chain
  4.5. Global Orthopedic Biomaterials Market Forecast
     4.5.1. Orthopedic Biomaterials Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Orthopedic Biomaterials Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Orthopedic Biomaterials Market Absolute $ Opportunity
5. Global Orthopedic Biomaterials Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Orthopedic Biomaterials Market Size and Volume Forecast by Applications
     5.3.1. Bio-resorbable Tissue Fixation
     5.3.2. Orthopedic Implants
     5.3.3. Joint Replacement/Reconstruction
     5.3.4. Orthobiologics
     5.3.5. Viscosupplementation
     5.3.6. Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Orthopedic Biomaterials Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Orthopedic Biomaterials Market Size and Volume Forecast by End Users
     6.3.1. Specialty Clinics
     6.3.2. Hospitals
     6.3.3. Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Orthopedic Biomaterials Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Orthopedic Biomaterials Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Orthopedic Biomaterials Demand Share Forecast, 2019-2026
8. North America Orthopedic Biomaterials Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Orthopedic Biomaterials Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Orthopedic Biomaterials Market Size and Volume Forecast by Applications
     8.4.1. Bio-resorbable Tissue Fixation
     8.4.2. Orthopedic Implants
     8.4.3. Joint Replacement/Reconstruction
     8.4.4. Orthobiologics
     8.4.5. Viscosupplementation
     8.4.6. Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Orthopedic Biomaterials Market Size and Volume Forecast by End Users
     8.7.1. Specialty Clinics
     8.7.2. Hospitals
     8.7.3. Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Orthopedic Biomaterials Demand Share Forecast, 2019-2026
9. Latin America Orthopedic Biomaterials Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Orthopedic Biomaterials Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Orthopedic Biomaterials Market Size and Volume Forecast by Applications
     9.4.1. Bio-resorbable Tissue Fixation
     9.4.2. Orthopedic Implants
     9.4.3. Joint Replacement/Reconstruction
     9.4.4. Orthobiologics
     9.4.5. Viscosupplementation
     9.4.6. Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Orthopedic Biomaterials Market Size and Volume Forecast by End Users
     9.7.1. Specialty Clinics
     9.7.2. Hospitals
     9.7.3. Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Orthopedic Biomaterials Demand Share Forecast, 2019-2026
10. Europe Orthopedic Biomaterials Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Orthopedic Biomaterials Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Orthopedic Biomaterials Market Size and Volume Forecast by Applications
     10.4.1. Bio-resorbable Tissue Fixation
     10.4.2. Orthopedic Implants
     10.4.3. Joint Replacement/Reconstruction
     10.4.4. Orthobiologics
     10.4.5. Viscosupplementation
     10.4.6. Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Orthopedic Biomaterials Market Size and Volume Forecast by End Users
     10.7.1. Specialty Clinics
     10.7.2. Hospitals
     10.7.3. Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Orthopedic Biomaterials Demand Share Forecast, 2019-2026
11. Asia Pacific Orthopedic Biomaterials Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Orthopedic Biomaterials Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Orthopedic Biomaterials Market Size and Volume Forecast by Applications
     11.4.1. Bio-resorbable Tissue Fixation
     11.4.2. Orthopedic Implants
     11.4.3. Joint Replacement/Reconstruction
     11.4.4. Orthobiologics
     11.4.5. Viscosupplementation
     11.4.6. Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Orthopedic Biomaterials Market Size and Volume Forecast by End Users
     11.7.1. Specialty Clinics
     11.7.2. Hospitals
     11.7.3. Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Orthopedic Biomaterials Demand Share Forecast, 2019-2026
12. Middle East & Africa Orthopedic Biomaterials Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Orthopedic Biomaterials Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Orthopedic Biomaterials Market Size and Volume Forecast by Applications
     12.4.1. Bio-resorbable Tissue Fixation
     12.4.2. Orthopedic Implants
     12.4.3. Joint Replacement/Reconstruction
     12.4.4. Orthobiologics
     12.4.5. Viscosupplementation
     12.4.6. Others
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Orthopedic Biomaterials Market Size and Volume Forecast by End Users
     12.7.1. Specialty Clinics
     12.7.2. Hospitals
     12.7.3. Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Orthopedic Biomaterials Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Orthopedic Biomaterials Market: Market Share Analysis
  13.2. Orthopedic Biomaterials Distributors and Customers
  13.3. Orthopedic Biomaterials Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Invibio Ltd
     13.4.2. DSM
     13.4.3. Globus Medical
     13.4.4. Zimmer Biomet
     13.4.5. Evonik Industries AG
     13.4.6. Stryker
     13.4.7. Exactech, Inc.
     13.4.8. Smith+Nephew
     13.4.9. Bioventus
     13.4.10. Mitsubishi Chemical America, Inc.
     13.4.11. CAM Bioceramics B.V.
     13.4.12. Heraeus Holding
     13.4.13. Medtronic
     13.4.14. DJO, LLC
     13.4.15. Arthrex, Inc.
     13.4.16. NuVasive®, Inc.

The global orthopedic biomaterials market has been segmented on the basis of

Material

  • Ceramics & Bioactive Glasses
  • Metal
  • Calcium Phosphate Cement
  • Polymers
  • Others

Application

  • Bio-resorbable Tissue Fixation
  • Orthopedic Implants
  • Joint Replacement/Reconstruction
  • Orthobiologics
  • Viscosupplementation
  • Others

End-user

  • Specialty Clinics
  • Hospitals
  • Others

Region

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • Invibio Ltd
  • DSM
  • Globus Medical
  • Zimmer Biomet
  • Evonik Industries AG
  • Stryker
  • Exactech, Inc.
  • Smith+Nephew
  • Bioventus
  • Mitsubishi Chemical America, Inc.
  • CAM Bioceramics B.V.
  • Heraeus Holding
  • Medtronic
  • DJO, LLC
  • Arthrex, Inc.
  • NuVasive®, Inc.

The competitive landscape of the global orthopedic biomaterials market report provides in-depth insights into the growth strategies and development initiatives implemented by the key players in the market.

Key players competing in the orthopedic biomaterials industry are Invibio Ltd; DSM; Globus Medical; Zimmer Biomet; Evonik Industries AG; Stryker; Exactech, Inc.; Smith+Nephew; Bioventus; Mitsubishi Chemical America, Inc.; CAM Bioceramics B.V.; Heraeus Holding; Medtronic; DJO, LLC; Arthrex, Inc. and NuVasive®, Inc.

  • On February 10, 2022, DePuy Synthes, an orthopedic unit of US healthcare giant Johnson & Johnson, acquired US-based foot and ankle company CrossRoads Extremity Systems.
  • On December 01, 2020, Zimmer Biomet a global solution provider for musculoskeletal disorders based in the US, acquired A&E Medical and its complete portfolio of sternal closure devices that include sternal sutures, cable systems, and rigid fixation along with punch products and pacing wires.
Global Orthopedic Biomaterials Market Share

Buy Report

FAQ Section

Some frequently asked quetions about this report!

Some of the key players in the orthopedic biomaterials market are Invibio Ltd; DSM; Globus Medical; Zimmer Biomet; Evonik Industries AG; Stryker; Exactech, Inc.; Smith+Nephew; Bioventus; Mitsubishi Chemical America, Inc.; CAM Bioceramics B.V.; Heraeus Holding; Medtronic; DJO, LLC; Arthrex, Inc.; and NuVasive®, Inc.

Through regional analysis, North America is likely to dominate the market during the projected period with a significant increase in bone disorder treatments and knee replacements.

The orthopedic implants segment constituted a key share of the orthopedic biomaterials market in 2022.

The market segmentation of the orthopedic biomaterials market is done on the basis of material, application, region, and end-user segments.

The key drivers for the orthopedic biomaterials market are an increase in the geriatric population, increasing musculoskeletal ailments, accidental injuries, and growing incidences of sports injuries.

The global orthopedic biomaterials market size was USD 15.5 Bn in 2022 and is likely to reach USD 38.7 Bn by 2031, expanding at a compound annual growth rate of 10.4% during 2023–2031.